BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21907315)

  • 1. Human bone marrow-derived stem cell proliferation is inhibited by hepatocyte growth factor via increasing the cell cycle inhibitors p53, p21 and p27.
    Chen K; Perez-Stable C; D'Ippolito G; Schiller PC; Roos BA; Howard GA
    Bone; 2011 Dec; 49(6):1194-204. PubMed ID: 21907315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocyte growth factor (HGF) and 1,25-dihydroxyvitamin D together stimulate human bone marrow-derived stem cells toward the osteogenic phenotype by HGF-induced up-regulation of VDR.
    Chen K; Aenlle KK; Curtis KM; Roos BA; Howard GA
    Bone; 2012 Jul; 51(1):69-77. PubMed ID: 22521434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
    Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R
    Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte growth factor (HGF) inhibits skeletal muscle cell differentiation: a role for the bHLH protein twist and the cdk inhibitor p27.
    Leshem Y; Spicer DB; Gal-Levi R; Halevy O
    J Cell Physiol; 2000 Jul; 184(1):101-9. PubMed ID: 10825239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte growth factor effects on mesenchymal stem cells: proliferation, migration, and differentiation.
    Forte G; Minieri M; Cossa P; Antenucci D; Sala M; Gnocchi V; Fiaccavento R; Carotenuto F; De Vito P; Baldini PM; Prat M; Di Nardo P
    Stem Cells; 2006 Jan; 24(1):23-33. PubMed ID: 16100005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cell cycle regulator p27kip1 contributes to growth and differentiation of osteoblasts.
    Drissi H; Hushka D; Aslam F; Nguyen Q; Buffone E; Koff A; van Wijnen A; Lian JB; Stein JL; Stein GS
    Cancer Res; 1999 Aug; 59(15):3705-11. PubMed ID: 10446985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Synergistic inhibitory effect of all-trans retinoic acid and 1,25-dihydroxy vitamin D3 on growth of human hepatoma cell line HepG2].
    Lu HQ; Zheng J
    Ai Zheng; 2006 Dec; 25(12):1470-6. PubMed ID: 17166369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest.
    Datta NS; Chen C; Berry JE; McCauley LK
    J Bone Miner Res; 2005 Jun; 20(6):1051-64. PubMed ID: 15883646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LYG-202 inhibits the proliferation of human colorectal carcinoma HCT-116 cells through induction of G1/S cell cycle arrest and apoptosis via p53 and p21(WAF1/Cip1) expression.
    Liu W; Dai Q; Lu N; Wei L; Ha J; Rong J; Mu R; You Q; Li Z; Guo Q
    Biochem Cell Biol; 2011 Jun; 89(3):287-98. PubMed ID: 21491996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte growth factor/scatter factor (HGF/SF) is produced by human bone marrow stromal cells and promotes proliferation, adhesion and survival of human hematopoietic progenitor cells (CD34+).
    Weimar IS; Miranda N; Muller EJ; Hekman A; Kerst JM; de Gast GC; Gerritsen WR
    Exp Hematol; 1998 Aug; 26(9):885-94. PubMed ID: 9694510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of hepatocyte growth factor-induced retinal endothelial cell migration and growth.
    Cai W; Rook SL; Jiang ZY; Takahara N; Aiello LP
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1885-93. PubMed ID: 10845613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intercellular adhesion molecule 1 discriminates functionally different populations of human osteoblasts: characteristic involvement of cell cycle regulators.
    Tanaka Y; Maruo A; Fujii K; Nomi M; Nakamura T; Eto S; Minami Y
    J Bone Miner Res; 2000 Oct; 15(10):1912-23. PubMed ID: 11028443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Akt regulates vitamin D3-induced leukemia cell functional differentiation via Raf/MEK/ERK MAPK signaling.
    Wang J; Zhao Y; Kauss MA; Spindel S; Lian H
    Eur J Cell Biol; 2009 Feb; 88(2):103-15. PubMed ID: 19058874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of differentiation/DNA binding proteins Id1 and Id3 are regulated by statins in endothelial cells.
    Pammer J; Reinisch C; Kaun C; Tschachler E; Wojta J
    Endothelium; 2004; 11(3-4):175-80. PubMed ID: 15370294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of osteoblast markers and induction of the glial fibrillary acidic protein by oncostatin M in osteosarcoma cells require PKCdelta and STAT3.
    Chipoy C; Berreur M; Couillaud S; Pradal G; Vallette F; Colombeix C; RĂ©dini F; Heymann D; Blanchard F
    J Bone Miner Res; 2004 Nov; 19(11):1850-61. PubMed ID: 15476586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of met proto-oncogene (hepatocyte growth factor receptor) expression during human monocyte-macrophage differentiation.
    Chen Q; DeFrances MC; Zarnegar R
    Cell Growth Differ; 1996 Jun; 7(6):821-32. PubMed ID: 8780895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyamine depletion in human melanoma cells leads to G1 arrest associated with induction of p21WAF1/CIP1/SDI1, changes in the expression of p21-regulated genes, and a senescence-like phenotype.
    Kramer DL; Chang BD; Chen Y; Diegelman P; Alm K; Black AR; Roninson IB; Porter CW
    Cancer Res; 2001 Nov; 61(21):7754-62. PubMed ID: 11691789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.
    Choi HR; Tucker SA; Huang Z; Gillenwater AM; Luna MA; Batsakis JG; El-Naggar AK
    Int J Oncol; 2003 Feb; 22(2):409-14. PubMed ID: 12527941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoclast differentiation is associated with transient upregulation of cyclin-dependent kinase inhibitors p21(WAF1/CIP1) and p27(KIP1).
    Okahashi N; Murase Y; Koseki T; Sato T; Yamato K; Nishihara T
    J Cell Biochem; 2001; 80(3):339-45. PubMed ID: 11135363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential role of diphenyleneiodonium, a flavoenzyme inhibitor, on p53-dependent and -independent cell cycle progression.
    Song JD; Kim KM; Kim KH; Kim CD; Kim JM; Yoo YH; Park YC
    Int J Oncol; 2008 Dec; 33(6):1299-306. PubMed ID: 19020764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.